GCP accreditation - A worthwhile investment [4]

South African Medical Journal

Volumn 96, Issue 3, 2006, Pages 161-162

  Burgess, Lesley J ^a   Sulzer, Nicky U ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ACCREDITATION; CLINICAL RESEARCH; EUROPEAN UNION; FORGERY; GOOD CLINICAL PRACTICE; HEALTH PROGRAM; HUMAN RIGHTS; INVESTMENT; LETTER; MEDICAL EDUCATION; MEDICAL ETHICS; MEDICAL RESEARCH; PRACTICE GUIDELINE; SOUTH AFRICA; STANDARD;

ACCREDITATION; BIOMEDICAL RESEARCH; CLINICAL TRIALS; HUMANS; QUALITY ASSURANCE, HEALTH CARE; RESEARCH PERSONNEL; SOUTH AFRICA;

EID: 33645306264     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Hartnett T. Investigator certification: A pivotal role to assuring trial quality. Clinical Researcher 2003; 3: 11-16.
2. Maloney DM. IRB's would have an increased role in International Research. Hum Res Rep 2002; 17: 9.
3. The European Group on Ethics in Science and New Technologies. Ethical Aspects of Clinical Research in Developing Countries. The European Group on Ethics in Science and New Technologies. Updated 2003. http://www.europa.eu.int/comm/european_group_ethics/doc/avis17_en.pdf (last accessed 2004).
4. The South African Department of Health. Guidelines for Good Practice in the Conducting of Clinical Trials with Human Participants in South Africa. Pretoria: DOH, 2000.
5. Haus M. Stakeholder congruence in contract research - an essential for our times. Pharmaceutical Journal. Updated: 2001. http://www.medpharm.co.za/sapj/jan/stakeholder.html (last accessed 2004).
6. European Union Clinical Trials Directive. Updated 22/03/2004. http://www.addenbrookes.org.uk/research/eu_clin_trials.html (last accessed 2005).